A detailed history of Lazard Asset Management LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 33,795 shares of MDXG stock, worth $308,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,795
Previous 10,036 236.74%
Holding current value
$308,210
Previous $69,000 188.41%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.65 - $7.76 $134,238 - $184,369
23,759 Added 236.74%
33,795 $199,000
Q2 2024

Aug 14, 2024

SELL
$6.16 - $8.08 $226,139 - $296,624
-36,711 Reduced 78.53%
10,036 $69,000
Q1 2024

May 14, 2024

SELL
$7.61 - $8.63 $4,779 - $5,419
-628 Reduced 1.33%
46,747 $359,000
Q4 2023

Feb 14, 2024

BUY
$5.7 - $9.14 $91,188 - $146,221
15,998 Added 50.99%
47,375 $415,000
Q3 2023

Nov 14, 2023

BUY
$6.35 - $8.16 $17,570 - $22,578
2,767 Added 9.67%
31,377 $228,000
Q2 2023

Aug 14, 2023

BUY
$3.14 - $6.61 $7,375 - $15,526
2,349 Added 8.94%
28,610 $189,000
Q1 2023

May 15, 2023

BUY
$2.97 - $4.81 $17,719 - $28,696
5,966 Added 29.4%
26,261 $89,000
Q4 2022

Feb 14, 2023

BUY
$2.63 - $3.45 $53,375 - $70,017
20,295 New
20,295 $56,000
Q1 2022

May 13, 2022

SELL
$4.27 - $6.27 $1,195 - $1,755
-280 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$5.7 - $8.48 $1,596 - $2,374
280 New
280 $1,000
Q2 2018

Aug 13, 2018

SELL
$5.39 - $8.96 $203,758 - $338,714
-37,803 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$6.69 - $17.96 $252,902 - $678,941
37,803 New
37,803 $263,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.04B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.